(PCTL) PCT LTD Discusses Their International Expan
Post# of 1425
(Total Views: 276)
Posted On: 02/01/2020 8:12:23 AM
(PCTL) PCT LTD Discusses Their International Expansion
Phoenix, Arizona--(Newsfile Corp. - January 8, 2020) - The Stock Day Podcast welcomed PCT LTD (OTC Pink: PCTL) ("the Company"
, a company that focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. President of the Company, Gary Grieco, joined Stock Day host Everett Jolly.
Jolly began the interview by noting that the Company recently deployed their Annihilyzer(R) Infection Control Systems in England, and asked what this move means for their future. "We recently shipped our system and got it all up and running," shared Grieco, adding that testing is set to begin January 15th. Grieco then expanded on the incredible potential of the product considering the current healthcare industry in England.
Jolly then asked about the Company's flagship product. "Systems that produce and effectively apply hypochlorous acid are the products that we manufacture," explained Grieco. "Hypochlorous Acid (HOCL) is a non-corrosive, very benign disinfectant," said Grieco, adding that the solution has existed for several years. He then explained that hypochlorous acid has been challenging to distribute in the past due to a short shelf life. "What we've done is we've taken our history of working with the product and developed a system for hospitals where it is generated on site and on demand," said Grieco.
"It is just a long arduous problem getting into the hospitals because of the layers of people that you have to go through," said Grieco. "We have found that from the initial discussion with a hospital, it takes about six months before we get a system in there," he explained. Grieco then shared that the Company has installed multiple systems in New York hospitals and are in discussions with additional New York facilities.
Jolly then noted the spread of disease in hospitals and asked how the Company's flagship product solves this issue. "It kills any tested pathogen, and by that I mean bacteria and viruses," said Grieco, noting that the system is also effective against C DIFF and MRSA.
"What's the competition in this space?", asked Jolly. Grieco explained that while hypochlorous acid is available through numerous competitors, the onsite generation of it by the system and application using electrostatic applicators is unique. "It's more than the product," said Grieco. "A room can be terminally disinfected once clean with our system within ten minutes, which would take thirty to forty minutes by hand," explained Grieco.
Jolly inquired about the Company's recent agreements and partnerships with SUNY Downstate Medical Center. Grieco explained that the SUNY facility chose to renew their contract with the Company for an additional five years after utilizing the system for one year. The Company has also been involved in testing gas wells with high levels of hydrogen sulfide, which is an extremely dangerous and corrosive compound. "Our results have been more than gratifying," shared Grieco.
The conversation then turned to the Company's entrance into the cannabis space. Grieco explained that companies in this space currently treat mold with peroxide, which is effective but costly. However, the Company is building a system that would be effective for both indoor and outdoor grow facilities in eliminating mold, E. coli, and salmonella. "Our initial testing has been spot on," said Grieco.
To close the interview, Grieco expressed his excitement in the Company's ability to face its challenges, as well as its incredible potential across numerous industries.
To hear Gary Grieco's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7473420-pct-ltd-d...ay-podcast
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/
About PCT LTD:
PCT LTD ("PCTL" focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements." Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the continued positive results relating to the installation of PCT"s Annihilyzer(R) systems in hospitals; the results of any manufacturers' representative and/or license agreements, actual sales revenue to be derived from agreements, if any such contract is executed; PCT LTD's and its subsidiary's business prospects; PCT LTD's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer(R) Infection Control Systems, "high-volume" equipment or its suitability for market applications, Hydrolyte(R) generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts
Company: PCTL
Phoenix, Arizona--(Newsfile Corp. - January 8, 2020) - The Stock Day Podcast welcomed PCT LTD (OTC Pink: PCTL) ("the Company"
, a company that focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. President of the Company, Gary Grieco, joined Stock Day host Everett Jolly. Jolly began the interview by noting that the Company recently deployed their Annihilyzer(R) Infection Control Systems in England, and asked what this move means for their future. "We recently shipped our system and got it all up and running," shared Grieco, adding that testing is set to begin January 15th. Grieco then expanded on the incredible potential of the product considering the current healthcare industry in England.
Jolly then asked about the Company's flagship product. "Systems that produce and effectively apply hypochlorous acid are the products that we manufacture," explained Grieco. "Hypochlorous Acid (HOCL) is a non-corrosive, very benign disinfectant," said Grieco, adding that the solution has existed for several years. He then explained that hypochlorous acid has been challenging to distribute in the past due to a short shelf life. "What we've done is we've taken our history of working with the product and developed a system for hospitals where it is generated on site and on demand," said Grieco.
"It is just a long arduous problem getting into the hospitals because of the layers of people that you have to go through," said Grieco. "We have found that from the initial discussion with a hospital, it takes about six months before we get a system in there," he explained. Grieco then shared that the Company has installed multiple systems in New York hospitals and are in discussions with additional New York facilities.
Jolly then noted the spread of disease in hospitals and asked how the Company's flagship product solves this issue. "It kills any tested pathogen, and by that I mean bacteria and viruses," said Grieco, noting that the system is also effective against C DIFF and MRSA.
"What's the competition in this space?", asked Jolly. Grieco explained that while hypochlorous acid is available through numerous competitors, the onsite generation of it by the system and application using electrostatic applicators is unique. "It's more than the product," said Grieco. "A room can be terminally disinfected once clean with our system within ten minutes, which would take thirty to forty minutes by hand," explained Grieco.
Jolly inquired about the Company's recent agreements and partnerships with SUNY Downstate Medical Center. Grieco explained that the SUNY facility chose to renew their contract with the Company for an additional five years after utilizing the system for one year. The Company has also been involved in testing gas wells with high levels of hydrogen sulfide, which is an extremely dangerous and corrosive compound. "Our results have been more than gratifying," shared Grieco.
The conversation then turned to the Company's entrance into the cannabis space. Grieco explained that companies in this space currently treat mold with peroxide, which is effective but costly. However, the Company is building a system that would be effective for both indoor and outdoor grow facilities in eliminating mold, E. coli, and salmonella. "Our initial testing has been spot on," said Grieco.
To close the interview, Grieco expressed his excitement in the Company's ability to face its challenges, as well as its incredible potential across numerous industries.
To hear Gary Grieco's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7473420-pct-ltd-d...ay-podcast
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/
About PCT LTD:
PCT LTD ("PCTL"
focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K. Forward-Looking Statements
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements." Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the continued positive results relating to the installation of PCT"s Annihilyzer(R) systems in hospitals; the results of any manufacturers' representative and/or license agreements, actual sales revenue to be derived from agreements, if any such contract is executed; PCT LTD's and its subsidiary's business prospects; PCT LTD's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer(R) Infection Control Systems, "high-volume" equipment or its suitability for market applications, Hydrolyte(R) generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts
Company: PCTL
(0)
(0)PCT Ltd. (PCTL) Stock Research Links
Scroll down for more posts ▼